September 2025
Successfully engineered immune-evasive human beta cells using CRISPR gene editing to enable pancreatic islet transplantation without immunosuppression, marking a breakthrough in diabetes treatment.
A comprehensive analysis of pathogenesis, modern classification systems, and the most current treatment paradigms for this complex lymphoproliferative disorder.
A focused briefing examining how surgical teams master robotic technologies, the metrics used to measure proficiency, and clinical implications for patient outcomes.